With a diverse background spanning precision medicine, business development, medical affairs, and drug development, Cecilia Schott develops and executes innovative global strategies that directly impact patients and drive commercial success. She currently serves as Vice President and Head of Precision Medicine Portfolio Planning at GlaxoSmithKline.
